Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Leukemia Research

Showing   of 12 results

Koen van Besien, MD, PhD

UH Seidman Expert Argues for More Focus on Combination Haplo-Cord Transplant

Innovations in Cancer | January 2025

Getty image lung cancer cell division

UH Seidman Cancer Center at ASH 2022

Innovations in Cancer | Winter 2023

UH Wesley Center Lab

Expansion of Wesley Center for Immunotherapy at University Hospitals Seidman Cancer Center Officially Opens

Addition brings more life-extending treatments and groundbreaking research to Northeast Ohio

Koen van Besien, MD, PhD

New Hematology Chief and Director of the Wesley Center for Immunotherapy Named for UH Seidman Cancer Center

Koen van Besien, MD, PhD, comes to UH Seidman Cancer Center from New York-Presbyterian Hospital

UH Seidman Cancer Center to Launch First-Ever Trial of NK Therapy and Vactosertib in Treating Colorectal Cancer and Hematological Malignancies

Trial employs new method of expanding and activating universal donor NK cells developed in Cleveland - Innovations in Cancer | Winter 2022

Team Led by UH Seidman Cancer Center Researcher Develops and Validates Three-in-One CAR T Therapy

Approach detailed in the journal Nature Communications shows therapeutic potential of BAFF CAR T for treating multiple B cell cancers, using mouse models with high effectiveness and minimum side effects - Innovations in Cancer | Winter 2022

UH Seidman Cancer Center Faculty Presentation Highlights from ASH 2021 and ASTRO 2021 Annual Meetings

Innovations in Cancer | Fall 2021

NK Cells illustration

Cleveland Team Develops New Method to Drive Robust Expansion and Activation of Natural Killer Cells

Approach promises to increase access to NK therapeutics - Innovations in Cancer | Fall 2021

Results are loading...